瘤坏死因子-阿尔法在结肠癌病理生理学的作用
Saleha Khan1, Yara Aldawood1, Ayesha Hanin Shaikh1
1General Medicine Practice Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia.
Diseases (Basel, Switzerland)
|June 25, 2025
概括
瘤坏死因子-α (TNF-α) 通过炎症途径驱动结肠癌的进展. 向TNF-α具有治疗潜力,但由于其在瘤生长和抑制方面的双重作用而面临挑战.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 结肠癌是全球主要的健康问题.
- 炎症途径,特别是涉及瘤亡因子-α (TNF-α),对于结肠癌的发展,进展和转移至关重要.
研究的目的:
- 综合审查TNF-α影响结肠癌进展的分子机制.
- 探索针对TNF-α在结肠癌治疗中的治疗潜力和挑战.
主要方法:
- 文献综述侧重于TNF-α在结肠癌中的分子机制.
- 对TNF-α与关键信号通路 (NF-κB,Wnt/β-catenin) 的相互作用进行分析.
- 对抗TNF-α疗法和组合策略的评估.
主要成果:
- TNF-α通过炎症信号传递促进结肠癌瘤发生和转移.
- 在瘤微环境中,TNF-α起着复杂的双重作用,可能抑制或促进瘤的进展.
- 抗TNF-α疗法显示出希望,但面临临临床挑战,由于这种二元性.
结论:
- TNF-α是结肠癌的关键调解者,突出了其作为治疗点的潜力.
- 目前正在探索组合策略,包括免疫检查点抑制剂.
- 克服耐药性和平衡TNF-α的影响对于有效的,个性化的结肠癌治疗至关重要.
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
240
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
240
Cancer-Critical Genes I: Proto-oncogenes
9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


